[Federal Register Volume 69, Number 6 (Friday, January 9, 2004)]
[Notices]
[Page 1574]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-437]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Use of Purified Invaplex From Gram 
Negative Bacteria as a Vaccine

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent No. 6,277,379 
entitled ``Use of Purified Invaplex from Gram Negative Bacteria as a 
Vaccine,'' filed August 21, 2001. Foreign rights are also available 
(PCT/US99/22772). The United States Government, as represented by the 
Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: A novel composition comprising Invaplex from 
gram-negative bacteria is described and is effective as a vaccine 
against gram-negative bacterial infection.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 04-437 Filed 1-8-04; 8:45 am]
BILLING CODE 3710-08-M